What is DCL Pathology?
DCL Pathology, a private laboratory headquartered in Indianapolis, has cultivated over three decades of specialized experience in clinical trials and fine needle biopsy services. The company is distinguished by its team of expert pathologists, renowned for their proficiency in anatomic and clinical pathology, with a particular emphasis on fine needle aspiration. DCL Pathology provides integrated pathology services to clinical trial sponsors and central laboratories worldwide, facilitating complex trials through its pioneering approach to minimally-invasive diagnostic procedures. To date, the company has successfully diagnosed over 50,000 cases, solidifying its reputation for diagnostic excellence.
How much funding has DCL Pathology raised?
DCL Pathology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in DCL Pathology
PPP
Public-Private Partnership
What's next for DCL Pathology?
The substantial large-scale late-stage funding indicates DCL Pathology is poised for significant expansion and further innovation. This strategic investment will likely fuel advancements in their diagnostic technologies, broaden their global reach in supporting clinical trials, and potentially enhance their service offerings in anatomic and clinical pathology. The company's focus on minimally-invasive diagnostics positions it well to capitalize on the growing demand for efficient and accurate patient assessment in both clinical research and routine diagnostics.
See full DCL Pathology company page
